Growth Metrics

Greater Cannabis Company, Inc. (GCAND) Common Equity (2017 - 2022)

Greater Cannabis Company (GCAND) has 6 years of Common Equity data on record, last reported at -$561429.0 in Q3 2022.

  • For Q3 2022, Common Equity fell 105.85% year-over-year to -$561429.0; the TTM value through Sep 2022 reached -$561429.0, down 105.85%, while the annual FY2021 figure was -$469062.0, 67.65% down from the prior year.
  • Common Equity reached -$561429.0 in Q3 2022 per GCAND's latest filing, up from -$641653.0 in the prior quarter.
  • Across five years, Common Equity topped out at $100779.0 in Q2 2018 and bottomed at -$2.4 million in Q1 2020.
  • Average Common Equity over 5 years is -$613760.9, with a median of -$561429.0 recorded in 2022.
  • Peak YoY movement for Common Equity: crashed 729.12% in 2019, then skyrocketed 91.68% in 2021.
  • A 5-year view of Common Equity shows it stood at -$563786.0 in 2018, then plummeted by 174.33% to -$1.5 million in 2019, then soared by 81.91% to -$279788.0 in 2020, then tumbled by 67.65% to -$469062.0 in 2021, then decreased by 19.69% to -$561429.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Common Equity were -$561429.0 in Q3 2022, -$641653.0 in Q2 2022, and -$616748.0 in Q1 2022.